muTarget

A cancer biomarker discovery platform linking transcriptomic, mutational and CNV alterations in solid tumors.

Features

muTarget lets you identify gene expression changes related to a gene mutation, and to identify mutations altering the expression of a selected gene.

Genotype Analysis
Identify genes that show altered expression in tumor samples harboring the selected mutation(s).
Target analysis
Discover mutations associated with altered expression of a selected target gene across tumor cohorts.
Copy Number Variations
Analyze the impact of copy number alterations on gene expression to uncover biomarkers.
Database
Integrates 24 different tumor types with over 10000 samples from diverse TCGA cancer studies for robust and reproducible analysis.
Rapid
Optimized for high-performance querying and interactive exploration, delivering results several times faster than muTarget v1 through a modern, efficient architecture.
Flexible
Enables customizable analyses across transcriptomic, somatic mutation and CNV data, supporting tailored workflows for biomarker and target discovery.

How to cite

If you use muTarget in your research, please cite:

Nagy Á., Győrffy B. muTarget: A platform linking gene expression changes and mutation status in solid tumors International Journal of Cancer, 2021;148:502-511

https://doi.org/10.1002/ijc.33283

A publication for muTarget v2 is in progress.